I had the privilege of becoming the Director of the National Institute of General Medical Sciences, one of the lead Institutes at the National Institutes of Health (NIH) for the National Centers for Biomedical Computing program, at the launch of the NIH Roadmap for Medical Research. This gave me a unique perspective from which to observe this program. The perspectives described herein are my own.
The emergence of the field of biomedical computing captured the attention of the leadership of the NIH toward the end of the 1990s. NIH Director Harold Varmus named a working group of the Advisory Committee to the Director 1 "to investigate the needs of NIH-supported investigators for computing resources, including hardware, software, networking, algorithms, and training." This project was termed the Biomedical Information Science and Technology Initiative (BISTI). The BISTI working group made four principal recommendations.
2 Their selfdescribed centerpiece of these recommendations was "to inaugurate National Programs of Excellence in Biomedical Computing." They noted that such "National Programs (are) the best opportunities (that) can be created for doing and learning at the interfaces among biology, mathematics, and computation."
The implementation of this recommendation became a component of the NIH Roadmap for Biomedical Research, a major initiative of the next NIH Director, Elias Zerhouni. 'Bioinformatics and Computational Biology' was one of nine major components of the NIH Roadmap, consisting of a single programdthe National Centers for Biomedical Computing (NCBCs). 3 A key aspect of all Roadmap programs was that they "span all areas of health and disease research and boundaries of NIH Institutes and Centers (ICs)" and that they "might not otherwise be supported by the NIH ICs because of their scope." Furthermore, the Roadmap was intended to be an 'incubator' where programs could be developed and then potentially 'adopted' by interested NIH ICs after Roadmap (now formalized as the NIH Common Fund) support ended. This reflects a tension that permeated the management of the NCBC program, that between the desire to develop centers with broad themes to optimize the utilization of computational expertise and the need to mesh the program with the disease, organ system, and life stage-focused institutes and centers whose missions are intended to be the prime potential beneficiaries of these centers. These considerations played a significant role in the development and management of the NCBC program. The first request for applications (RFA) for NCBCs was issued in September 2003 and four NCBCs were subsequently funded. A second RFA in the next year and three additional centers were funded. The management of these centers was widely distributed across NIH ICs, with both non-categorical ICs such as the National Institute of General Medical Sciences, the National Center for Research Resources, the National Institute for Biomedical Imaging and Bioengineering, and the National Library of Medicine, and categorical ICs such as the National Cancer Institute, the National Institute on Drug Abuse, and the National Human Genome Research Institute playing leading roles, and staff members from many other ICs actively participating. In concert with the NIH, the NCBCs themselves worked to form a national network rather than a set of separate centers. In 2009, an RFA was issued to allow these centers to compete for renewal with additional applicants. This resulted in the renewal of five of the centers and the addition of one additional center. Note that each of the awards in the second phase required substantial co-funding from interested ICs to supplement decreasing Common Fund support.
The BISTI working group report discussed the potential impact of enhancing biomedical computing. They stated:
"With National Programs of Excellence bringing together interdisciplinary teams, researchers will be able to harness the power of tomorrow's computers by collaborating to develop mathematical models, write software, and adapt systems. They can make computers useful research tools, from highperformance systems in biomedical laboratories to ultra-high-performance systems in national centers. Such teams can help biomedical research move to a new horizon where new paradigms, ideas, and techniques can emerge..
.The focus of the National Programs of Excellence in Biomedical Computing will be research; the subtext will be the opportunity to bring together related specialties and train a new generation of researchers whose skills cross-disciplinary boundaries."
The NCBC program has demonstrated that this potential can be achieved. Although the number of centers (never exceeding a steady state of seven) was close to the minimum number recommended by the BISTI working group, the network of NCBCs covered a substantial amount of the biomedical landscape. The major programmatic mechanism utilized to focus effort on particular topics was the incorporation of 'driving biological projects.' Some driving biological problems involved very basic biological questions such as generating threedimensional models of RNA molecules and the prediction and analysis of binding sites for DNA-binding proteins. Others involved quite applied challenges in clinical research such as the extraction of useful information from electronic medical records and the effective sharing of medical information in a manner consistent with privacy considerations. These and other driving biological problems and the associated software tools are described in the accompanying articles from the NCBC teams.
It has now been 12 years since the release of the BISTI report. Considerable progress has been made on the integration of information technology into biomedical research in addition to that supported by the NCBC program. First and foremost, the use of computational tools has become routine in almost all biomedical research projects. A range of software tools are widely utilized, thanks to broad distribution over the internet, and numerous databases are readily available.
Second, the fields of systems biology and biomedical informatics, critically dependent on computational tools, have evolved from concepts to relatively well established disciplines, including the formation of several academic departments.
In the face of this progress, other advances in biomedical technology are increasing the need for accelerated progress and increased investment in biomedical computing. Innovations in numerous areas, including DNA sequencing, cellular imaging, and mass spectrometry, are yielding ever increasing amounts of data in need of analysis. These events were anticipated in the BISTI report:
"Inevitably, those needs will grow as biology moves increasingly from a benchbased to a computer-based science, as models replace some experiments and complement others, as lone researchers are supplemented by interdisciplinary teams. The overarching need is for an intellectual fusion of biomedicine and information technology."
Well-conceived and executed software tools have the potential to impact biomedical research broadly and deeply. The avalanche of data and the potential benefits from successful data mining and analysis dictate that software will be generated. The crucial question is how the most effective and accessible software can be generated in a cost-effective manner, avoiding the duplicative generation of tools of potentially lower quality. Furthermore, the need for appropriately trained individuals who can contribute effectively to biomedical computational projects is greater than ever. Even in the present challenging fiscal climate, the biomedical community and the NIH need to consider the potential impact of targeted investments in biomedical computing, including a continuation and perhaps an expansion of a national network of biomedical computing centers, perhaps after a more systematic analysis examining the effectiveness of this approach for achieving these goals.
